CAS No. |
469-59-0 |
中文名称 |
(2'R,3S,3'R,3a'S,6aS,6bS,6'S,7a'R,11aS,11bR)-3-羟基-3',6',10,11b-四甲基-1,3,3a' ,4,4',5',6,6a,6b,6',7,7',7a',8,11a,11b-十六氢-3'H-螺[苯并[a]芴-9,2' -呋喃并[3,2-b]吡啶] -11(2H)-酮 |
英文名称 |
(2'R,3S,3'R,3a'S,6aS,6bS,6'S,7a'R,11aS,11bR)-3-Hydroxy-3',6',10,11b-tetramethyl-1,3,3a',4,4',5',6,6a,6b,6',7,7',7a',8,11a,11b-hexadecahydro-3'H-spiro[benzo[a]fluorene-9,2'-furo[3,2-b]pyridin]-11(2H)-one |
别名 |
NSC7520 | NSC-7520 | CCG-208226 | Spiro[9H-benzo[a]fluorene-9,2-b]-pyridin]-11(1H)-one,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a,11b-hexadecahydro-3-hydroxy-3',6',10,11b-tetramethyl- | Spiro(9H-benzo(a)fluorene-9,2'(3'H)-furo(3,2-b)-pyridin)-11(1H)-one, 2 |
标准英文名 |
(3S,3'R,3a'S,6aS,6bS,6'S,7a'R,9R,11aS,11bR)-3-hydroxy-3',6',10,11b-tetramethyl-2,3,3a',4,4',5',6,6a,6b,6',7,7',7a',8,11a,11b-hexadecahydro-3'H-spiro[benzo[a]fluorene-9,2'-furo[3,2-b]pyridin]-11(1H)-one |
MDL No. |
MFCD01684066 |
分子式 |
C27H39NO3 |
分子量 |
425.61
|
精确分子量 |
425.29
|
SMILES |
CC1=C2C(=O)[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C |
标准SMILES |
C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2C(=O)C2[C@H]1CC[C@]1(O[C@@H]3C[C@H](C)CN[C@H]3[C@H]1C)C=2C |
用途 |
Jervine (11-Ketocyclopamine) is an inhibitor of the Hedgehog signaling pathway (IC50 = 500–700 nM), acting through interaction with Smoothened to suppress Sonic Hedgehog (Shh) signaling; it is used in research to study craniofacial development and Shh-related teratogenesis, as it induces mandibular hypoplasia and tooth agenesis in embryos, mimicking Shh mutant phenotypes; it also reduces chondrocyte proliferation in vitro without affecting cell morphology or Alcian blue staining intensity. |
InChIKey |
CLEXYFLHGFJONT-DNMILWOZSA-N |